Valéria Brito Oliveira

RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients

Marcia Regina Dezan, Ingrid Helena Ribeiro, Valéria Brito Oliveira et al. · Blood Cells Molecules and Diseases · 2017 · 36 citations · Full text

Sequencing, Medicine, Genetics +9

‐318C/T polymorphism of the <i><scp>CTLA</scp>‐4</i> gene is an independent risk factor for <scp>RBC</scp> alloimmunization among sickle cell disease patients

Valéria Brito Oliveira, Marcia Regina Dezan, Francisco C. A. Gomes et al. · International Journal of Immunogenetics · 2017 · 21 citations

Effectiveness of a red cell antigen‐matching transfusion protocol in sickle cell disease patients

Marcia Regina Dezan, Valéria Brito Oliveira, J. V. S. Bianchi et al. · ISBT Science Series · 2016 · 15 citations

Immunohematology, Antibody Development, Scp S +16

Defining the clinical relevance of red blood cell autoantibodies by Monocyte Monolayer Assay

Marina C. A. V. Conrado, Amanda N. D'Avila, Juliana Borges Vieira et al. · Journal of Clinical Laboratory Analysis · 2017 · 12 citations · Full text

Evaluation of the applicability and effectiveness of a molecular strategy for identifying weak D and DEL phenotype among D– blood donors of mixed origin exhibiting high frequency of <i>RHD*Ψ</i>

Marcia Regina Dezan, Luis Giovani Oliveira Guardalini, Elaine Pessoa et al. · Transfusion · 2017 · 11 citations